SGLT2 inhibitor as GDMT in an elderly female with chronic HFpEF
An 81-year-old homebound, obese (BMI, 31 kg/m2) female complained of dyspnoea on exertion and exercise intolerance in 2023. The patient often needed to stop after walking for a distance of two blocks or climbing eight steps of stairs (New York Heart Association [NYHA] functional class II), which limited her daily and social activities.

New Molecule

4 New

New Indication

7 New

New Brand

20 New

Markings
Shape
Form
Color 1
Color 2
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in